cools alexander (27 Ergebnisse)

Hardcover. Zustand: Good+. Hardcover 1973 library bound edition. Ex-library book with stamps and labels attached. Binding firm. Pages unmarked and clean. Covers in plain carboard with library tape binding. Original paper cover bound with book has some creasing. [149 p. : ill. ; 24 cm].

Hardback. Zustand: Very Good+. Laminated boards, binding tight, dedication to previous owner written on front endpaper, otherwise text unmarked. ; 6.5 X 1.25 X 9.5 inches; 519 pages.

Hard Cover. Zustand: Good -. No Jacket. Usual ex-library features. The interior is clean and tight. Two pages are creased. Binding and cover are good. The book has been library hardbound. 149 pages. Ex-Library.

Zustand: very good. New York : Psychology Press, 1988. Hardcover. 527 pp. - Contents: Section I: A.R. Cools, Introduction. A.R. Green, Behavioural Pharmacology of 5-HT: An Introduction. T.P. Blackburn, D.A. Martin, P. Slater, Is Rotational Behaviour in the Rat a 5-HT1A or 5-HT1B Mediated Response? A.J. Stoessl, C.T. Dourish, S.D. Iversen, Serotonic Mediated Behaviour Following Central or Peripheral Administration of the Selective NK-3 Tachykinin Agonist Senktide. Section II: P. Bevan, 5-HT and Sexual Behavior. S. Ahlenius, K. Larsson, New Aspects on the Serotonergic Modulation of Male Rat Sexual Behaviour. S.D. Mendelson, B.B. Gorzalka, Differential Roles of 5-HT Receptor Subtypes in Female Sexual Behaviour. M.D. James, S.M. Lane, D.R. Hole, C.A. Wilson, Hypothalamic Sites of Action of the Dual Effect of 5-HT on Female Sexual Behaviour in the Rat. L. R nyi, T. Lewander, 5-HT1A and 5-HT1B Agonists Produce Opposite Effects on the Ejaculatory Response Induced by Amphetamine in Rats. H.H.G. Berendsen, R.J.M. Smets, C.L.E. Broekkamp, Functional Interplay of Serotonin(5-HT)-Receptor Subtypes. Section III: P. Bevan, 5-HT and Aggression. B. Olivier, J. Mos, M. Tulp, J. Schipper, P. Bevan, Modulatory Action of Serotonin in Aggressive Behaviour. K.A. Miczek, P. Donat, Brain 5-HT System and Inhibition of Aggressive Behaviour. D.C. Blanchard, K. Hori, R.J. Rodgers, C.A. Hendrie, R.J. Blanchard, Differential Effects of Benzodiazepines and 5-HT1A Agonists on Defensive Patterns in Wild Rattus. C. Gentsch, M. Lichtsteiner, H. Feer, Competition for Sucrose-Pellets in Triads of Male, Wistar Rats, the Effects of Eight 5-HT- Agonists. Section IV: A.R. Cools, Depression and Psychosis. P. Willner, Towards a Theory of Serotonergic Dysfunction in Depression. J.F.W. Deakin, 5-HT Receptor Subtypes in Depression. J.A.M. van der Heyden, Modulation of the 5-HT System and Antipsychotic Activity. G.A. Kennet, G. Curzon, Mechanism of Action of 8-OH-DPAT on a Rat Model for Human Depression. P. Martin, A.M. Laporte, P. Soubrie, E. El Mestikawy, M. Hamon, Reversal of Helpless Behaviour in Rats by Serotonin Uptake Inhibitors. T.F. Meert, C.J.E. Niemegeers, Y.G. Gelders, P.A.J. Janssen, Ritanserin (R 55 667), an Original Thymosthenic. N.M. Barnes, B. Costall, A.M. Domeney, M.E. Kelly, R.J. Naylor, M.B. Tyers, The Abilities of 5-HT3 Antagonists to Inhibit the Hyperreactivity Caused by Dopamine Infusion into the Nucleus Accumbens of the Rat. M.A. Geyer, 5-HT2 Antagonists Increase Tactile Startle Habituation in an Animal Model of a Habituation Deficit in Schizophrenia. Section V: A.R. Cools, Feeding Behaviour. E. Goodall, T. Silverstone, Pharmacological Evidence for the Involvement of Serotonergic Mechanisms in Human Feeding. R. Samanin, Serotonin and Feeding. P.H. Hutson, G.A. Kennett, T.P. Donohoe, C.T. Dourish, G. Curzon, Opposite Effects of 5-HT1A and 5-HT1B/1C agonists on Food Intake. J.D. Leander, Effects of Selective Serotonergic Agonists on Palatability-Induced Ingestion. A.M.J. Montgomery, P. Willner, R. Muscat, 8-OH-DPAT Reliably Increases Ingestio Condition : very good copy. ISBN 9780805801354. Keywords : PSYCHOLOGY, Serotonin.

Zustand: New. pp. 528.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Paperback. Zustand: Brand New. 519 pages. 8.75x6.00x1.00 inches. In Stock.

Zustand: New. Alexander R. Cools, Paul Bevan, Paul Bevan Duphar, Trevor ArcherThis volume reviews the current state of research within the behavioral pharmacology of 5-HT. The book opens exciting new approaches to the interdisciplinary study of behavior and ph.

Hardcover. Zustand: Fair. Aus Bibliothek aussortiert. The introduction of chlorpromazine in 1953, and haloperidol in 1958, into clinical practice dramatically altered the therapy of schizophrenic patients. Although representing by no means a cure for this severe psychiatric ill­ ness, it allowed, for the first time, to adequately control the severe hallu­ cinations and delusional beliefs which prevent these patients from leading a more or less independent life. Indeed these antipsychotics (and the many congeners that were to follow) significantly reduced the number ofchronic schizophrenic inpatients in psychiatric clinics all over the world. However soon after their introduction it became clear that, like all other available drugs, antipsychotics were by no means miracle drugs. In fact, two major problems appeared. First, the antipsychotics had very little effect on the so-called negative or defect symptoms, like social isolation, apathy and anhedonia, and secondly virtually all antipsychotics produced a number of side-effects, of which the neurological (often called extra­ pyramidal) side-effects were the most troublesome. Especially the tardive dyskinesia, which occurred in about 15 to 20% of the patients after pro­ longed treatment, represented a major problem in the treatment of schizo­ phrenic patients.

Taschenbuch. Zustand: Neu. Neuware.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: Gebraucht / Used. Goed d1144e.

Gebunden. Zustand: New. Alexander R. Cools, Paul Bevan, Paul Bevan Duphar, Trevor ArcherThis volume reviews the current state of research within the behavioral pharmacology of 5-HT. The book opens exciting new approaches to the interdisciplinary study of behavior and ph.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Buch. Zustand: Neu. Neuware - This volume reviews the current state of research within the behavioral pharmacology of 5-HT. The book opens exciting new approaches to the interdisciplinary study of behavior and pharmacology with special reference to ethology, endocrinology, neuroanatomy and comparative aspects of drug action, and notes new developments in therapeutic drugs of the future.

Zustand: New. This is a Brand-new US Edition. This Item may be shipped from US or any other country as we have multiple locations worldwide.

Zustand: New.

Zustand: New.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The introduction of chlorpromazine in 1953, and haloperidol in 1958, into clinical practice dramatically altered the therapy of schizophrenic patients. Although representing by no means a cure for this severe psychiatric ill ness, it allowed, for the first time, to adequately control the severe hallu cinations and delusional beliefs which prevent these patients from leading a more or less independent life. Indeed these antipsychotics (and the many congeners that were to follow) significantly reduced the number ofchronic schizophrenic inpatients in psychiatric clinics all over the world. However soon after their introduction it became clear that, like all other available drugs, antipsychotics were by no means miracle drugs. In fact, two major problems appeared. First, the antipsychotics had very little effect on the so-called negative or defect symptoms, like social isolation, apathy and anhedonia, and secondly virtually all antipsychotics produced a number of side-effects, of which the neurological (often called extra pyramidal) side-effects were the most troublesome. Especially the tardive dyskinesia, which occurred in about 15 to 20% of the patients after pro longed treatment, represented a major problem in the treatment of schizo phrenic patients.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The introduction of chlorpromazine in 1953, and haloperidol in 1958, into clinical practice dramatically altered the therapy of schizophrenic patients. Although representing by no means a cure for this severe psychiatric ill ness, it allowed, for the first time, to adequately control the severe hallu cinations and delusional beliefs which prevent these patients from leading a more or less independent life. Indeed these antipsychotics (and the many congeners that were to follow) significantly reduced the number ofchronic schizophrenic inpatients in psychiatric clinics all over the world. However soon after their introduction it became clear that, like all other available drugs, antipsychotics were by no means miracle drugs. In fact, two major problems appeared. First, the antipsychotics had very little effect on the so-called negative or defect symptoms, like social isolation, apathy and anhedonia, and secondly virtually all antipsychotics produced a number of side-effects, of which the neurological (often called extra pyramidal) side-effects were the most troublesome. Especially the tardive dyskinesia, which occurred in about 15 to 20% of the patients after pro longed treatment, represented a major problem in the treatment of schizo phrenic patients.

Zustand: New. Deals with drugs which play an important role in the therapy of schizophrenia. This book describes the introduction of the first antipsychotics on the market and the importance of clozapine for further investigation of other potentially atypical antipsychotics, which may have an important impact on the therapy. Editor(s): Ellenbroek, Bart A.; Cools, Alexander R.; Parnham, M. J. Series: Milestones in Drug Therapy. Num Pages: 247 pages, biography. BIC Classification: MMGW; MMH. Category: (P) Professional & Vocational; (UP) Postgraduate, Research & Scholarly. Dimension: 234 x 156 x 15. Weight in Grams: 532. . 2000. Hardback. . . . . Books ship from the US and Ireland.

Buch. Zustand: Neu. Neuware -The aim of the International Basal Ganglia Society (IBAGS) is to further our understanding of normal basal ganglia function and the pathophysiology of disorders of the basal ganglia, including Parkinson's disease, Huntington's disease, and schizophrenia. Each triennial meeting of IBAGS brings together basic research scientists from all disciplines as well as clinicians who are actively involved in the treatment of basal ganglia disorders, to discuss the most recent advances in the field and to generate new approaches and ideas for the future.This volume comprises the proceedings of the 9th meeting of IBAGS, held in Egmond aan Zee, The Netherlands, September 2nd-6th, 2007.Springer Verlag GmbH, Tiergartenstr. 17, 69121 Heidelberg 632 pp. Englisch.

Buch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The aim of the International Basal Ganglia Society (IBAGS) is to further our understanding of normal basal ganglia function and the pathophysiology of disorders of the basal ganglia, including Parkinson's disease, Huntington's disease, and schizophrenia. Each triennial meeting of IBAGS brings together basic research scientists from all disciplines as well as clinicians who are actively involved in the treatment of basal ganglia disorders, to discuss the most recent advances in the field and to generate new approaches and ideas for the future.This volume comprises the proceedings of the 9th meeting of IBAGS, held in Egmond aan Zee, The Netherlands, September 2nd-6th, 2007.

Taschenbuch. Zustand: Neu. Druck auf Anfrage Neuware - Printed after ordering - The aim of the International Basal Ganglia Society (IBAGS) is to further our understanding of normal basal ganglia function and the pathophysiology of disorders of the basal ganglia, including Parkinson's disease, Huntington's disease, and schizophrenia. Each triennial meeting of IBAGS brings together basic research scientists from all disciplines as well as clinicians who are actively involved in the treatment of basal ganglia disorders, to discuss the most recent advances in the field and to generate new approaches and ideas for the future.This volume comprises the proceedings of the 9th meeting of IBAGS, held in Egmond aan Zee, The Netherlands, September 2nd-6th, 2007.

Paperback. Zustand: Brand New. 632 pages. 9.20x6.10x1.26 inches. In Stock.

Hardcover. Zustand: Brand New. 1st edition. 262 pages. 9.40x6.20x1.90 inches. In Stock.